MARKET

RCKT

RCKT

ROCKET PHARMACEU
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.49
+0.78
+5.30%
After Hours: 15.49 0 0.00% 16:00 04/08 EDT
OPEN
15.08
PREV CLOSE
14.71
HIGH
15.50
LOW
14.19
VOLUME
411.36K
TURNOVER
--
52 WEEK HIGH
27.59
52 WEEK LOW
9.01
MARKET CAP
853.05M
P/E (TTM)
-9.7995
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RCKT stock price target is 36.29 with a high estimate of 46.00 and a low estimate of 31.00.

EPS

RCKT News

More
  • More COVID-19 actions - healthcare
  • seekingalpha · 6d ago
  • Rocket Pharmaceuticals Provides Business Update in Light of COVID-19 Pandemic
  • Business Wire · 6d ago
  • Rocket Pharmaceuticals provides business update in light of COVID-19 pandemic
  • Seeking Alpha - Article · 6d ago
  • Rocket Pharma Reports Continues To Believe Will Achieve 2020 Milestones, Highlights Capital Will Be Sufficient Into 2022
  • Benzinga · 6d ago

Industry

Biotechnology & Medical Research
+3.06%
Pharmaceuticals & Medical Research
+2.82%

Hot Stocks

Symbol
Price
%Change

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapy treatment options for rare, devastating diseases. The Company’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The Company’s lead clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer. Its additional pipeline programs for bone marrow-derived disorders are for Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis (IMO). The Company is also developing an AAV-based gene therapy program for pediatric heart failure indication, Danon disease.
More

Webull offers kinds of Rocket Pharmaceuticals Inc stock information, including NASDAQ:RCKT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RCKT stock news, and many more online research tools to help you make informed decisions.